Child treated with gene editing therapy for the first time by a team of Philadelphia doctors
Read Original Source
The world's first patient to be treated with personalized gene editing therapy is finally headed home after over 300 days in the hospital. Nine-month-old KJ Muldoon recently underwent CRISPR-based gene editing by a team at Children's Hospital of Philadelphia and Penn Medicine in a historical medical breakthrough. The landmark study published in The New England Journal of Medicine showcases the power of customized gene editing therapy to treat patients with rare metabolic disease.
AI Summary
Main Idea: A Philadelphia team at Children’s Hospital of Philadelphia and Penn Medicine used custom gene editing therapy to treat baby KJ Muldoon, marking a medical first for a child with a rare metabolic disease.
Key Points:
- KJ Muldoon is the first patient to receive a gene editing treatment made for his specific genetic problem.
- The therapy used CRISPR, a tool that edits DNA, to target the gene causing his illness.
- Before treatment, KJ faced dangerous ammonia buildup that can harm the brain and cause lasting damage.
- Doctors say his condition has improved a lot, and they hope the result could lead to new treatments for other rare diseases.
Impact on the People
Negative Impact
The treatment is experimental and very costly, so most patients may not get access soon.
Positive Impact
CHOP and Penn Medicine’s success could speed better gene therapies for rare diseases and give families new options beyond transplant.
How did each entity affect people?
Rate how each entity in this article affected the American people.
- Primary:KJ Muldoonperson
- Primary:Penn Medicineeducational / research institution
Candidate Entities10 candidates · 5 weighted vote min · 70% decision
- KJ MuldoonpersonPrimaryEvaluated
The child at the center of the article and the first patient to receive the personalized gene editing.
Include 0 (0%)Ignore 0 (0%)5 to threshold - Penn Medicineeducational / research institutionPrimaryEvaluated
Central medical institution involved in the personalized gene editing treatment.
Include 0 (0%)Ignore 0 (0%)5 to threshold - Childrens Hospital of Philadelphiaeducational / research institutionPrimaryAI selected
Central institution that treated KJ and is directly tied to the medical breakthrough.
Include 0 (0%)Ignore 0 (0%)5 to threshold - Dr. Kiran MusunurupersonMajorAI selected
University of Pennsylvania doctor quoted as a key member of the gene-editing team.
Include 0 (0%)Ignore 0 (0%)5 to threshold - Dr. Rebecca Ahrens-NicklaspersonMajorAI selected
CHOP doctor quoted as a central medical lead explaining the disease and treatment impact.
Include 0 (0%)Ignore 0 (0%)5 to threshold - University of Pennsylvaniaeducational / research institutionMajorAI selected
Named institution associated with the gene-editing work and one of the doctors quoted.
Include 0 (0%)Ignore 0 (0%)5 to threshold - Kyle MuldoonpersonContextCandidate
KJ’s father, quoted describing the difficult treatment decision and his son’s progress.
Include 0 (0%)Ignore 0 (0%)5 to threshold
Comments 0
Comments here are the same thread shown when this article appears in The Pulse.
No comments on this article yet.
Sign in to comment